Acquisitions - Denovium Narrative (Details) - USD ($) $ in Thousands	1 Months Ended
	Jan. 31, 2021	Jun. 30, 2022	Jan. 31, 2022	Dec. 31, 2021
Business Acquisition
Restricted cash		$ 15,017		$ 10,513
Goodwill		$ 21,335		$ 21,335
Denovium
Business Acquisition
Total purchase consideration	$ 3,038
Payment of upfront consideration and working capital adjustments	2,500
Restricted cash	2,500
Compensation expense			$ 2,500
Goodwill	$ 1,055
Denovium | Common Stock
Business Acquisition
Shares issued as consideration (shares)	1,010,296
Percentage of shares subjected to stock restriction agreement (percent)	80.00%
Shares subjected to stock restriction agreement (shares)	808,238
Vesting period (years)	4 years
Fair value of stock restriction agreement	$ 1,500
Percentage of shares not subjected to stock restriction agreement (percent)	20.00%
Shares not subjected to stock restriction agreement (shares)	202,058